These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis. Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706 [TBL] [Abstract][Full Text] [Related]
3. [Painting by number--Survival curves and Kaplan-Meier method]. Schindler B; Briel M; Günther J Med Monatsschr Pharm; 2015 May; 38(5):186-91. PubMed ID: 26364408 [TBL] [Abstract][Full Text] [Related]
5. Kaplan-Meier Survival, Actuarial Survival, Censoring, and Competing Events-What Is What? Hage A; Hage F Ann Thorac Surg; 2022 Jul; 114(1):40-43. PubMed ID: 35367199 [TBL] [Abstract][Full Text] [Related]
6. Drawing Guideline for Kim J J Korean Med Sci; 2019 Mar; 34(8):e35. PubMed ID: 30833878 [TBL] [Abstract][Full Text] [Related]
7. A practical guide to understanding Kaplan-Meier curves. Rich JT; Neely JG; Paniello RC; Voelker CC; Nussenbaum B; Wang EW Otolaryngol Head Neck Surg; 2010 Sep; 143(3):331-6. PubMed ID: 20723767 [TBL] [Abstract][Full Text] [Related]
8. Understanding survival analysis: actuarial life tables and the Kaplan-Meier plot. Barakat A; Mittal A; Ricketts D; Rogers BA Br J Hosp Med (Lond); 2019 Nov; 80(11):642-646. PubMed ID: 31707885 [TBL] [Abstract][Full Text] [Related]
9. An overview on standard statistical methods for assessing exposure-outcome link in survival analysis (Part II): the Kaplan-Meier analysis and the Cox regression method. Abd ElHafeez S; Torino C; D'Arrigo G; Bolignano D; Provenzano F; Mattace-Raso F; Zoccali C; Tripepi G Aging Clin Exp Res; 2012 Jun; 24(3):203-6. PubMed ID: 23114547 [TBL] [Abstract][Full Text] [Related]
10. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes. Chiba Y Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455 [TBL] [Abstract][Full Text] [Related]
11. [Survival curves]. Skovlund E Tidsskr Nor Laegeforen; 2018 Jun; 138(11):. PubMed ID: 29947200 [No Abstract] [Full Text] [Related]
12. Analysis of the probability and risk of cause-specific failure. Caplan RJ; Pajak TF; Cox JD Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1183-6. PubMed ID: 7521864 [TBL] [Abstract][Full Text] [Related]
13. Survival analysis, part 2: Kaplan-Meier method and the log-rank test. Koletsi D; Pandis N Am J Orthod Dentofacial Orthop; 2017 Oct; 152(4):569-571. PubMed ID: 28962743 [No Abstract] [Full Text] [Related]
14. Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications. Thorén FB; Anderson H; Strannegård Ö Cancer Immunol Immunother; 2013 Oct; 62(10):1547-51. PubMed ID: 23979447 [TBL] [Abstract][Full Text] [Related]
15. Measures of follow-up in time-to-event studies: Why provide them and what should they be? Betensky RA Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565 [TBL] [Abstract][Full Text] [Related]
16. [Kaplan-Meier analysis]. Tripepi G; Catalano F G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021 [TBL] [Abstract][Full Text] [Related]
17. Assessment of gastric cancer survival: using an artificial hierarchical neural network. Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544 [TBL] [Abstract][Full Text] [Related]
18. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail. Gong Q; Fang L Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424 [TBL] [Abstract][Full Text] [Related]